Nestor F. Esnaola, MD, MPH, MBA, FACS

Professor of Surgery, Academic Institute
Full Member, Research Institute
Associate Director, Cancer Control and Population Science, Cancer Center
Houston Methodist


Dr. Nestor Esnaola is division head of surgical oncology, Department of Surgery, Surgical Director, and Cancer Center Associate Director, Cancer Control and Population Science. 

Description of Research

Dr. Esnaola will lead cancer center efforts in the areas of cancer prevention, community outreach and engagement, cancer health disparities, and population science research in accordance with NCI cancer center guidelines.


US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials
Regnante, JM, Richie, NA, Fashoyin-Aje, L, Vichnin, M, Ford, M, Roy, UB, Turner, K, Hall, LL, Gonzalez, E, Esnaola, NF, Clark, LT, Adams, HC, Alese, OB, Gogineni, K, McNeill, L, Petereit, D, Sargeant, I, Dang, J, Obasaju, C, Highsmith, Q, Lee, SC, Hoover, SC, Williams, EL & Chen, MS 2019, Journal of oncology practice, vol. 15, no. 4, pp. e289-e299.

Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism
Nguyen-Lee, JJ, Paciuc, M, Guerra, R, Esnaola, NF, Zanocco, KA & Zheng, F 2019, Surgery (United States).

Does the Surgical Apgar Score predict serious complications after elective major cancer surgery?
Goel, N, Manstein, SM, Ward, WH, DeMora, L, Smaldone, MC, Farma, JM, Uzzo, RG & Esnaola, NF 2018, Journal of Surgical Research, vol. 231, pp. 242-247.

Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas
Fareed, MM, DeMora, L, Esnaola, NF, Denlinger, CS, Karachristos, A, Ross, EE, Hoffman, J & Meyer, JE 2018, Journal of Gastrointestinal Oncology, vol. 9, no. 4, pp. 762-768.

Granular cell tumor experience at a comprehensive cancer center
Moten, AS, Movva, S, von Mehren, M, Wu, H, Esnaola, NF, Reddy, SS & Farma, JM 2018, Journal of Surgical Research, vol. 226, pp. 1-7.

Comparative Effectiveness and Risks of Bowel Preparation before Elective Colorectal Surgery
Koller, SE, Bauer, KW, Egleston, BL, Smith, R, Philp, MM, Ross, HM & Esnaola, NF 2018, Annals of Surgery, vol. 267, no. 4, pp. 734-742.

Availability of patient-centered cancer support services: A statewide survey of cancer centers
Cartmell, KB, Sterba, KR, Pickett, K, Zapka, J, Alberg, AJ, Sood, AJ & Esnaola, NF 2018, PLoS ONE, vol. 13, no. 3, e0194649.

Mismatch repair deficiency testing in patients with colorectal cancer and nonadherence to testing guidelines in young adults
Shaikh, T, Handorf, EA, Meyer, JE, Hall, MJ & Esnaola, NF 2018, JAMA Oncology, vol. 4, no. 2, e173580.

Optimal preoperative assessment of the geriatric patient
Ward, WH, Manstein, SM, Goel, N, Chow, WB, Ko, CY, Rosenthal, RA & Esnaola, NF 2017, Perioperative Care and Operating Room Management, vol. 9, pp. 33-38.

A structured framework for optimizing surgical quality through process-of-care trials
Waingankar, N, Esnaola, NF & Uzzo, RG 2017, Urologic Oncology: Seminars and Original Investigations, vol. 35, no. 5, pp. 177-179.

Splenic irradiation for splenomegaly: A systematic review
Zaorsky, NG, Williams, GR, Barta, SK, Esnaola, NF, Kropf, PL, Hayes, SB & Meyer, JE 2017, Cancer Treatment Reviews, vol. 53, pp. 47-52.

Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma
Esnaola, NF, Meyer, JE, Karachristos, A, Maranki, JL, Camp, ER & Denlinger, CS 2016, Cancer, vol. 122, no. 9, pp. 1349-1369.

Optimal Perioperative Management of the Geriatric Patient: A Best Practices Guideline from the American College of Surgeons NSQIP and the American Geriatrics Society
Mohanty, S, Rosenthal, RA, Russell, MM, Neuman, MD, Ko, CY & Esnaola, NF 2016, Journal of the American College of Surgeons, vol. 222, no. 5, pp. 930-947.

The orphan drug act restoring the mission to rare diseases
Daniel, MG, Pawlik, TM, Fader, AN, Esnaola, NF & Makary, MA 2016, American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 39, no. 2, pp. 210-213.

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer
Esnaola, NF, Chaudhary, UB, OBrien, P, Garrett-Mayer, E, Camp, ER, Thomas, MB, Cole, DJ, Montero, AJ, Hoffman, BJ, Romagnuolo, J, Orwat, KP & Marshall, DT 2014, International Journal of Radiation Oncology Biology Physics, vol. 88, no. 4, pp. 837-844.

Surgical Management of Pancreatic Neoplasms: What’s New?
Karachristos, A & Esnaola, NF 2014, Current gastroenterology reports, vol. 16, no. 8.

The impact of lymph node disease in extremity soft-tissue sarcomas: A population-based analysis
Johannesmeyer, D, Smith, V, Cole, DJ, Esnaola, NF & Camp, ER 2013, American Journal of Surgery, vol. 206, no. 3, pp. 289-295.

Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients
Yang, Y, Mauldin, PD, Ebeling, M, Hulsey, TC, Liu, B, Thomas, MB, Camp, ER & Esnaola, NF 2013, Cancer, vol. 119, no. 8, pp. 1512-1520.

Pneumatosis intestinalis after open jejunostomy tube placement
Selander, C, Pullatt, R, Esnaola, NF & Camp, ER 2013, American Surgeon, vol. 79, no. 2.

Optimal preoperative assessment of the geriatric surgical patient: A best practices guideline from the American college of surgeons national surgical quality improvement program and the American geriatrics society
Chow, WB, Rosenthal, RA, Merkow, RP, Ko, CY & Esnaola, NF 2012, Journal of the American College of Surgeons, vol. 215, no. 4, pp. 453-466.

Live Chat Available